Episodes (Page 30)
✨
AESGP celebrates 60 years in self-care.
Jurate Svarcaite
✨
PhRMA's suit against Medicare price negotiation dismissed.
✨
Generic industry faces sustainability challenges.
✨
Shanghai's new biotech policy discussed.
Brian Yang
Dexter Yan
Kevin Grogan
✨
South Korea prioritizes innovative R&D for pharma.
✨
Diagnostics execs discuss sepsis and cancer tests.
Lishan Aklog
Mark McDonough
Rollie Carlson
✨
BeiGene co-founder discusses China biotech innovation.
Xiaodong Wang
✨
Biggest drug launches expected in 2024.
✨
AI's potential in consumer health platforms.
Nick Tate
✨
CES 2024 highlights in digital health.
✨
Robotics can increase access to cell therapies.
✨
Bayer's pipeline; J&J's M&A approach.
✨
AliveCor discusses patent infringement case against Apple.
Sanjay Voleti
✨
Janet Woodcock honored as an FDA leader.
✨
Expert insights on treating elderly LBCL patients.
Oncologist Donald Fleming
✨
AI's impact on consumer health and wellness.
Nick Tate
✨
J.P. Morgan meeting reveals industry optimism.
✨
FDA advisory committee schedule is open.
✨
Key takeaways from JPM 2024 for China biotech.
Jing Li
Leon Tang
✨
J.P. Morgan meeting highlights and takeaways.